Panhematin (RECORDATI RARE DISEASES, INC.)
Welcome to the PulseAid listing for the Panhematin drug offered from RECORDATI RARE DISEASES, INC.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | RECORDATI RARE DISEASES, INC. |
| NON-PROPRIETARY NAME: | hemin |
| SUBSTANCE NAME: | HEMIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1983-07-20 |
| END MARKETING DATE: | 2020-01-24 |
Panhematin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Panhematin from RECORDATI RARE DISEASES, INC. |
| LABELER NAME: | RECORDATI RARE DISEASES, INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7(mg/mL) |
| START MARKETING DATE: | 1983-07-20 |
| END MARKETING DATE: | 2020-01-24 |
| PRODUCT ID: | 55292-701_cdfd9947-bc51-43c9-9bd0-130c214bb68a |
| PRODUCT NDC: | 55292-701 |
| APPLICATION NUMBER: | BLA101246 |
Other HEMIN Pharmaceutical Manufacturers / Labelers:
